Global Pharmaceutical Carbohydrate Excipients Market Growth 2025-2031

The global Pharmaceutical Carbohydrate Excipients market size is predicted to grow from US$ 1760 million in 2025 to US$ 2470 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.

Pharmaceutical carbohydrate excipients refer to carbohydrate substances used as excipients in pharmaceutical preparations. They usually originate from natural plant or animal resources, such as starch, glucose, sucrose, and lactose, and have multiple functions and uses. These excipients primarily serve as stabilizers in pharmaceutical preparations, maintaining the physical and chemical stability of drugs and preventing degradation or deterioration during storage and transportation. At the same time, they can also serve as energy sources, providing necessary energy support for drugs and thereby enhancing their efficacy. Furthermore, pharmaceutical carbohydrate excipients can improve the taste and flavor of drugs, making them more acceptable and easier for patients to take. During the pharmaceutical manufacturing process, the types and quantities of pharmaceutical carbohydrate excipients require strict screening and control to ensure the safety and effectiveness of the drugs.

United States market for Pharmaceutical Carbohydrate Excipients is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pharmaceutical Carbohydrate Excipients is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pharmaceutical Carbohydrate Excipients is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pharmaceutical Carbohydrate Excipients players cover Pfanstiehl, ADM, Protheragen-ING, DFE Pharma, Meggle-Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Carbohydrate Excipients Industry Forecast” looks at past sales and reviews total world Pharmaceutical Carbohydrate Excipients sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Carbohydrate Excipients sales for 2025 through 2031. With Pharmaceutical Carbohydrate Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Carbohydrate Excipients industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Carbohydrate Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Carbohydrate Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Carbohydrate Excipients market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Carbohydrate Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Carbohydrate Excipients.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Carbohydrate Excipients market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Sucrose
Glucose
Starch
Others

Segmentation by Application:
Oral Preparations
Injectable Preparations
Topical Preparations
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfanstiehl
ADM
Protheragen-ING
DFE Pharma
Meggle-Pharma
Roquette
Kerry Group
Colorcon
Signet
IMCD
SPI Pharma
Huakang Pharma
Hanjiang Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Carbohydrate Excipients market?

What factors are driving Pharmaceutical Carbohydrate Excipients market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Carbohydrate Excipients market opportunities vary by end market size?

How does Pharmaceutical Carbohydrate Excipients break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.